The next Abraham Accords should formalize what has already been built

The next Abraham Accords should formalize existing cooperation rather than initiate it, drawing a parallel to Israel's pre-state institutional development. A U.S.-sponsored Middle East pharmaceutical security framework is proposed as a starting point. This framework would allow countries like Saudi Arabia, Qatar, Oman, and Kuwait to participate in technical workstreams without requiring immediate diplomatic recognition with Israel. The focus would be on essential generic medicines, addressing shared vulnerabilities in supply chains and leveraging manufacturing capacity from countries like Egypt, Jordan, and Israel, alongside the purchasing power and capital from Gulf nations. The United States could facilitate this through the FDA and State Department, aiming for regional redundancy in pharmaceutical supply and potentially leading to a Middle East Medicines Agency.